depressive disorder

Mindfulness and Bodily Distress.

Mindfulness and bodily distress.

Filed under: Depression Treatment

Dan Med J. 2012 Nov; 59(11): B4547
Fjorback LO

We have created a mindfulness approach to treat patients who experience multiple, persistent, and disabling physical symptoms that cannot be explained by a well-defined medical or surgical condition. Randomized controlled trials in this area are few, and research is hampered by the lack of clear definitions. Bodily distress syndrome (BDS) or bodily stress is an empirically defined definition unifying various conditions such as fibromyalgia, chronic fatigue syndrome, and somatization disorder. In the present PhD, we explored whether patients suffering from BDS may be committed to mental training in the form of mindfulness therapy, which is a mindfulness program specifically targeted patients suffering from BDS. The theoretical model for including mindfulness training in the treatment of BDS is based on identified neurobiological impairments in these patients and the neurobiological improvements that mindfulness training may offer. BDS is a major public health issue possibly associated with the pathology of the immuno-endocrine and autonomic nervous system. BDS patients are often stigmatized, and effective treatment is rarely delivered, which leaves these patients isolated, left by themselves, vulnerable to potentially harming medical and/or alternative treatments. Accordingly, there is a need for non-harming practical tools that patients can learn to master so that they can improve the ability to take responsibility for their own health and wellbeing. Mindfulness-Based Stress Reduction (MBSR) is a group program that employs mindfulness practice to alleviate suffering associated with physical, psychosomatic, and psychiatric disorders. Mindfulness-Based Cognitive Therapy (MBCT) is designed to prevent depressive relapse. Paper I and II present systematic literature reviews only of randomized controlled trials on MBSR and MBCT. The effect of MBSR has been explored on fibromyalgia in three studies, none of them showed convincing results, but gave some indications as to improvement. The reviews recommended MBSR as a useful method for improving mental health; however, lack of long-term follow-up and active control groups are limitations in most studies. MBCT was recommended as a tool for preventing depressive relapse in recovered, recurrently depressed patients, but the implication of MBSR and MBCT is problematic, especially due to the lack of well educated mindfulness teachers. We combined MBSR with cognitive behavioral therapy, CBT, specifically targeted BDS. Paper III provides original data from 119 patients enrolled in a randomized clinical trial, mindfulness therapy for BDS. The randomized controlled trial indicates that BDS patients are capable of and willing to engage in mindfulness therapy. This thesis showed that mindfulness therapy can safely and successfully engage BDS patients in mindfulness practice. Since individual CBT and psychiatric consultation have previously been found to have positive outcomes for BDS patients, we compared mindfulness therapy to an active control group entitled specialized treatment in which an individual treatment was planned in collaboration between the patient and an MD specialized in BDS, CBT, and psychiatry. Mindfulness therapy was comparable to specialized treatment in improving the quality of life and the symptoms of the patients with BDS at 15-month follow-up. For primary outcome physical health (PCS) at 15-month follow-up, different developments over time for the two treatment groups could not be established (F(3,2674) = 1.51, p = 0.21). However, in the mindfulness therapy group, PCS significant changed at the end of treatment and this change remained at 15-month follow-up, whereas no significantly change was seen in the specialized treatment group until at the 15-month follow-up. In the mindfulness therapy group, 26%; CI: 14-38 reported a marked improvement (> 1 SD) at the end of treatment compared with 10%; CI: 2-18 in the specialized treatment group. This amounts to a statistically… Continue reading

Depression Treatment: Recognizing Poststroke Depression.

Recognizing poststroke depression.

Filed under: Depression Treatment

Nursing. 2012 Dec; 42(12): 60-3
Schneider MA, Schneider MD

HubMed – depression

 

Effects of cortisol on memory in women with borderline personality disorder: role of co-morbid post-traumatic stress disorder and major… Continue reading

Depression – Treatment for Depression – What Causes Depression Video.rv


 

Depression – Treatment for Depression – What Causes Depression Video.rv – How much to know about of the depressive disorder? In this video, you will be able to know the nervous answer from the neuron inside, and perhaps to… Continue reading

Comparative Study of Regional Homogeneity in Schizophrenia and Major Depressive Disorder.

Comparative study of regional homogeneity in schizophrenia and major depressive disorder.

Filed under: Depression Treatment

Am J Med Genet B Neuropsychiatr Genet. 2012 Nov 20;
Chen J, Xu Y, Zhang K, Liu Z, Xu C, Shen Y, Xu Q… Continue reading

VAL66MET BDNF GENOTYPES in MELANCHOLIC DEPRESSION: EFFECTS on BRAIN STRUCTURE and TREATMENT OUTCOME.

VAL66MET BDNF GENOTYPES IN MELANCHOLIC DEPRESSION: EFFECTS ON BRAIN STRUCTURE AND TREATMENT OUTCOME.

Filed under: Depression Treatment

Depress Anxiety. 2012 Nov 16;
Cardoner N, Soria V, Gratacòs M, Hernández-Ribas R, Pujol J, López-Solà M, Deus J, Urretavizcaya M, Estivill… Continue reading

Depression Treatment: Cognitive Functioning in Pediatric Transverse Myelitis.

Cognitive functioning in pediatric transverse myelitis.

Filed under: Depression Treatment

Mult Scler. 2012 Nov 19;
Harder LL, Holland AA, Frohman E, Graves D, Greenberg BM

BACKGROUND: Transverse myelitis (TM) is an inflammatory disease of the spinal cord. In pediatric… Continue reading

Depression Treatment: Poor Sleep in Patients With Multiple Sclerosis.

Poor sleep in patients with multiple sclerosis.

Filed under: Depression Treatment

PLoS One. 2012; 7(11): e49996
Bøe Lunde HM, Aae TF, Indrevåg W, Aarseth J, Bjorvatn B, Myhr KM, Bø L

Poor sleep is a frequent symptom in patients with multiple sclerosis (MS). Sleep may be influenced by MS-related symptoms and adverse effects from immunotherapy and symptomatic medications. We aimed to study the prevalence of poor sleep and the influence of socio-demographic and clinical factors on sleep quality in MS- patients.A total of 90 MS patients and 108 sex-and age- matched controls were included in a questionnaire survey. Sleep complaints were evaluated by Pittsburgh Sleep Quality Index (PSQI) and a global PSQI score was used to separate good sleepers (?5) from poor sleepers (>5). Excessive daytime sleepiness, the use of immunotherapy… Continue reading

Rapid Response With Ketamine on Suicidal Cognition in Resistant Depression.

Rapid response with ketamine on suicidal cognition in resistant depression.

Filed under: Depression Treatment

Indian J Psychol Med. 2012 Apr; 34(2): 170-5
Thakurta RG, Das R, Bhattacharya AK, Saha D, Sen S, Singh OP, Bisui B

Suicidal ideation in… Continue reading

TRPM8 Ion Channel Ligands for New Therapeutic Applications and as Probes to Study Menthol Pharmacology.

TRPM8 Ion Channel Ligands for New Therapeutic Applications and as Probes to Study Menthol Pharmacology.

Filed under: Addiction Rehab

Life Sci. 2012 Nov 15;
Journigan VB, Zaveri NT

Since the discovery of the TRPM8 gene in 2001, the TRPM8… Continue reading